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 First report of triterpenoid elicitation by a phytohormone in C. reinhardtii
 MeJA treatment (1 mM) arrested the growth and up-regulated genes of the MEP 
pathway
 Highlighting a specialised pathway branching immediately upstream of cycloartenol
 Accumulation of an uncharacterised triterpenoid secondary metabolite (C30H52O3)
 Plant-like MeJA response machinery is putatively absent in C. reinhardtii
2
ABSTRACT
Terpenoids are a large and diverse class of naturally occurring metabolites serving many 
industrial applications and natural roles. Economically important terpenoids are often 
produced in low abundance from their natural sources, making their industrial-scale 
production challenging or uneconomical, therefore engineered microorganisms are frequently 
used as heterologous production platforms. Photosynthetic microorganisms, such as the green 
alga Chlamydomonas reinhardtii, represent promising systems to produce terpenoids in a 
cost-effective and sustainable manner, but knowledge about the regulation of their terpenoid 
metabolism remains limited. Here we report on the investigation of the phytohormone methyl 
jasmonate (MeJA) as elicitor of algal terpenoid synthesis. We treated C. reinhardtii cells in 
mid-exponential growth phase with three different concentrations of MeJA (0.05, 0.5 and 
1 mM). The highest concentration of MeJA affected the photosynthetic activity of the cells, 
arrested the growth and up-regulated key genes of the 2-C-methyl-D-erythritol 4-phosphate 
(MEP) pathway, leading to a significant increase in intermediates of this pathway, squalene 
and (S)-2,3-epoxysqualene, while the abundance of cycloartenol, and two main sterols 
(ergosterol and 7-dehydroporiferasterol) decreased. These data suggest the redirection of the 
carbon flux towards the synthesis of yet uncharacterised triterpenoid secondary metabolites 
upon MeJA treatment. Our results offer important new insights into the regulation of the 
triterpenoid metabolism in C. reinhardtii and raise important questions on hormonal 
signalling in microalgae. Phytohormone treatment is tested for the first time in algae, where it 
holds great potential for identifying key transcriptional regulators of the MEP pathway as 
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1. INTRODUCTION
Terpenoids (isoprenoids) are the largest class of natural compounds, which are involved in a 
myriad of cellular processes. Their diverse biological activities have found applications in 
multiple industrial products (pharmaceutics, nutraceutics, agriculture, chemicals, 
flavours/fragrances, colourants, fuels/fuel additives) [1, 2]. Most commercially relevant 
terpenoids known today are isolated from higher plants, but their industrial production is often 
challenging or uneconomical, as they are produced in low abundance and only under specific 
conditions. Thus, their production and extraction from plants requires large amounts of 
biomass, the yields can vary significantly from batch to batch and the extraction/purification 
processes are labour intensive and expensive [2-4]. Further, the chemical synthesis of these 
compounds, when possible, is often too costly and complex, as correct chirality is usually 
required [1]. In light of these challenges, bioengineering of microbes for the production of 
terpenoids in controlled bioreactors has emerged as a viable solution. The model organisms 
Saccharomyces cerevisiae (yeast) and Escherichia coli (bacteria) are typically chosen as 
heterologous hosts for terpenoid production due to the relative ease of cultivation, the detailed 
knowledge of their metabolism and their genetic tractability [1]. The use of these organisms, 
however, is driven by their well-developed genetic toolbox rather than their terpenoid 
metabolism [5], as both yeast and bacteria do not naturally synthesise plant metabolites. 
Moreover, both organisms rely on organic carbon sources for growth; consequently adding 






























































photosynthetic microbial hosts have emerged as a carbon-neutral alternative to commonly 
used fermentative systems, as they have the ability to convert inorganic carbon (CO2) into 
useful biochemicals [6]. Proof-of-principle heterologous terpenoid expression have been 
reported for cyanobacteria, the diatom Phaeodactylum tricornutum and the model eukaryotic 
green microalga Chlamydomonas reinhardtii [7-10]; however, as of today, these organisms 
are less tractable and often produce lower yields than engineered E. coli and yeast. 
The universal terpenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl 
diphosphate (DMAPP) are naturally produced via two independently evolved isoprenoid 
pathways: the mevalonate (MVA) pathway and the methyl-D-erythritol 4-phosphate (MEP) 
pathway, of which C. reinhardtii only possesses the latter [11]. IPP and DMAPP are then 
condensed to geranyl diphosphate (GPP), farnesyl diphosphate (FPP) and geranylgeranyl 
diphosphate (GGPP), which are the ‘building blocks’ of specialised terpenoids (Figure 1). The 
heterologous synthesis of terpenoids generally consists in the expression of enzymes or even 
entire biosynthetic pathways, which connect to endogenous terpenoid metabolism and convert 
the prenyl phosphate substrates into the desired product [9, 12, 13]. Engineering of upstream 
terpenoid pathways (MVA and/or MEP) is usually necessary to obtain higher yields [1, 12]. 
In C. reinhardtii, IPP and DMAPP must be generated entirely from the MEP pathway in the 
chloroplast (Figure 1). For sustainable and cost-effective production of terpenoids in 
microalgae, metabolic engineering of the MEP pathway is necessary to increase the flow of 
carbon towards the production of terpenoids precursors [7, 11]. However, very little is known 
about the MEP pathway regulation and the mechanisms of IPP and DMAPP transport in C. 
reinhardtii. A number of promising strategies have been suggested for MEP pathway 
deregulation in photosynthetic microorganisms, such as the inhibition of competing metabolic 
pathways, gene over-expression, screening of enzyme variants with increased activity, 






























































investigated a plant hormone, methyl jasmonate (MeJA), as a potential elicitor of the MEP 
pathway in C. reinhardtii. Plants produce MeJA as a signalling compound in response to 
biotic and abiotic stresses (e.g., pathogen attack, herbivory and wounding), triggering a 
complex signalling cascade that rapidly reprograms cell metabolism and physiology for 
defence [15, 16]. MeJA is a well-known elicitor of secondary metabolism in plant tissues and 
exogenous treatment with this hormone has been shown to trigger the biosynthesis of all three 
major classes of secondary metabolites (i.e. terpenoids, phenylpropanoids/flavonoids, and 
alkaloids) involved in development and defence mechanisms [3, 17-21]. In higher plants, 
MeJA is known to upregulate the MEP pathway [22, 23] and has been used as an elicitor to 
increase the production of high-value terpenoids, such as the synthesis of the anti-cancer 
agent paclitaxel (Taxol®) in suspension cultures of Taxus cell [24]. 
Although naturally occurring jasmonate signalling has never been reported in microalgae, one 
study has examined the effect of MeJA on the primary metabolism of C. reinhardtii cells, 
showing a profound perturbation of the central carbon flux and saturated fatty acid 
metabolism [25]; however, the effect of MeJA on the production of terpenoids by C. 
reinhardtii remains unexplored. Here, we thoroughly investigated the effects of the plant 
hormone on the production of triterpenoids and isoprenoids precursors in C. reinhardtii. This 
study is one of the first attempts aiming to elucidate the regulation of terpenoid metabolism in 
C. reinhardtii. It sets the basis of future metabolic engineering works for the heterologous 
production of terpenoids in algae. In the long-term, the knowledge generated will contribute 




























































































Figure 1. Overview of terpenoid biosynthesis in C. reinhardtii. The enzymes of the 
methylerythritol 4-phosphate (MEP) pathway are nucleus-encoded and post-translationally 
imported into the chloroplast [11]. The FPP synthase of C. reinhardtii is associated with the 
endoplasmic reticulum [9]. GPP was not detected in this study, therefore a question mark is 
included. The nature of the transporter(s) responsible for the transfer of prenyl diphosphates 
accross the plastid membrane is unknown. ER, endoplasmic reticulum; GAP, glyceraldehyde 
3-phosphate; PGA, 3-phosphoglyceric acid; DMAPP, dimethylallyl diphosphate; IPP, 
isopentenyl diphosphate; MEP, methylerythritol 4-phosphate; FPP, farnesyl diphosphate; 
GGPP, geranylgeranyl diphosphate; GPP, geranyl diphosphate. Adapted from [9, 12].
2. MATERIALS AND METHODS
2.1.  Strains and culture conditions
The Chlamydomonas reinhardtii wild-type strain CC-125 mt+ [137c] was cultivated under 
mixotrophic conditions in Tris-acetate-phosphate (TAP) medium [26] at 26°C under 






























































constant agitation at 110 rpm. The cultures were started at a cell density of 105 cells mL-1 in 
1L baffled Erlenmeyer flasks.
2.2.  Bioinformatics analysis
In order to mine for plant-like MeJA response machinery in C. reinhardtii, translated 
sequences of the Arabidopsis thaliana genes coronatine-insensitive-1 (COI1, AT2G39940.1), 
the transcription factor MYC2 (AT1G32640), members of the Jasmonate Zim domain family 
(JAZ1, AT1G19180.1), JAZ2 (At1g74950), JAZ3 (AT3G17860), JAZ6 (AT1G72450), JAZ9 
(AT1G70700) and JAZ10 (AT5G13220) were used as query for BLASTp searches conducted 
on the Chlamydomonas reinhardtii v5.5 proteome in the Phytozome database 
(https://phytozome.jgi.doe.gov), where the latest (v5.6) gene models are housed, using 
standard settings, on the 20/12/2018, and for iterative search through Jackhmmr 
(https://www.ebi.ac.uk/Tools/hmmer/search/jackhmmer) with the standard settings using 
Hidden Markov Models of each query protein family (Supplementary Material).
2.3.  Methyl jasmonate treatments
The effect of methyl jasmonate (MeJA) on C. reinhardtii was assessed by treating mid-log 
phase cultures (cell density of 5 x 105 – 1 x106 cells mL-1) with three different final 
concentrations of MeJA (0.05, 0.5 and 1 mM). The stock solutions of MeJA were diluted in 
pure ethanol and prepared so the cultures were all injected with 1% (v/v) ethanol, including 
the controls. Three biological replicates were used per treatment. 






























































Samples (0.5 mL) were extracted from the flasks at 0, 12 and 48 hours, fixed with 0.2 μm 
filtered glutaraldehyde at a final concentration of 2% and stored at 4 °C in the dark. A 10 μL 
aliquot was pipetted into a haemocytometer (Neubauer, Germany) and viewed under a Nikon 
Eclipse compound microscope (Nikon, Japan) at 10 x magnification. Cells were allowed to 
settle into the focal plane for 5 min before 12 images of haemocytometer squares were 
recorded (Nikon DS-Qi2). Images were processed on ImageJ software (version 2.0) using a 
custom script to calculate number of cells mL-1. 
2.5.  Chlorophyll a fluorescence measurement
Pulse-amplitude modulated fluorometry (PAM) was used to measure the maximum quantum 
yield of photosystem II (Fv/Fm calculated as Fv = Fm – Fo, where Fo is the minimum 
fluorescence in the dark and Fm the maximum fluorescence) for rapid assessment of C. 
reinhardtii photosynthetic activity during the experiment, and to monitor for any photosystem 
stress caused by MeJA treatment. The measurements were taken with a POCKET-PAM 
(Gademann Instruments GmbH, Germany) after 10 min of dark acclimation. These 
measurements were performed at room temperature with the following settings: blue light, 
measuring light intensity <0.2 mmol photons m-2 s-1 PAR, saturation pulse intensity of 2,700 
µmol photons m-2 s-1 PAR, and saturation pulse width of 0.6 s.
2.6.  Metabolites extraction and quantification 
2.6.1. Triterpenoid analysis
For triterpenoid analysis, 20 mL of algal culture were harvested at 48 hours after treatment. 
The cells were pelleted at 4,000 x g for 5 min at 4°C, rinsed once with phosphate buffered 






























































measured before extracting the metabolites. Extraction and gas chromatography–mass 
spectrometry (GC–MS) analyses were performed as described in [27]. 
2.6.2. Isoprenoid analysis
For the analysis of 2-C-methyl-D-erythritol 4-phosphate (MEP), 2-C-methyl-D-erythritol-2,4-
cyclodiphosphate (MEcPP), geranyl diphosphate (GPP), geranylgeranyl pyrophosphate 
(GGPP) and farnesyl pyrophosphate (FPP), 40 mL of algal suspension were washed with 160 
mL and 50 mL of cold PBS, respectively and extracted as described by Canelas et al. [28] 
using PBS instead of methanol and by keeping the samples at -2˚C instead of -40˚C. Ten µM 
of Azidothymidine (AZT) was used as internal standard. MEP, MEcPP, GPP, GGPP and FPP 
were analysed using a previously described LC-MS/MS method with slight modifications 
[29]. Authentic standards were kindly provided by A/Prof Claudia Vickers (University of 
Queensland, Australia). Samples were analysed in multiple reaction monitoring mode on a 
mass spectrometer (Agilent 6490 Triple Quadrupole) with ESI source (negative ion mode). 
Following transitions were monitored with fragmentor voltage of 380 V. MEP (m/z 520 → 
322, 520 → 97, 520→ 79, collision energy (CE) -18 eV), MEcPP (m/z 277 → 179, 277 → 
97, 277 → 79, CE -15eV), GGPP (m/z 449 → 431, 449 →159, 449 → 79, CE -18eV) and 
FPP (m/z 381 → 363, 381 → 159, 381 → 79 CE -15eV). Chromatographic separation was 
performed on an Agilent 1290 LC system with a Phenomenex C-6 phenyl analytical column 
(250 mm × 4.6 mm, 5 μm). The mobile phase, consisted of 20 mmol/L ammonium 
hydrogencarbonate solution (A) and Water/Acetonitrile (1∶9, v/v) (B), pumped at a flow rate 
of 1 mL/min. LC separation was performed using a linear gradient program as follows: 5 % B 
until 1 min, ramped to 100 % B at 10 min, held until 12 min, ramped down to 5 % B at 6 min 






























































plotted using analytical standards. The concentrations were normalized to the internal 
standard (AZT) and a total of 108 cells.
2.6.3. Pigments analysis
Extraction of carotenoids (including chlorophyll a, chlorophyll b and β-carotene) was carried 
out using 1.5 mL of chilled HPLC-grade acetone and kept in the dark prior to pigment 
analysis by HPLC-UV. Samples were vortexed for 30 seconds (x 3 times) and stored at -20°C 
overnight. Pigment extracts were then filtered through 0.2 μm PTFE 13 mm syringe filters 
and stored at -80°C until analysis. An Agilent 1290 Infinity LC HPLC System equipped with 
a binary pump with integrated vacuum degasser, thermostatic column compartment modules, 
an Agilent 1290 Infinity Autosampler and PDA (photo-diode array) detector was used for 
analysis. A Zorbax Eclipse XDB C8 HPLC 4.6 mm × 150 mm and guard column (Agilent) 
was used by eluting a gradient of tetrabutyl alkylammonium acetate (TBAA) methanol mix 
(30:70) (Solvent A) and methanol (Solvent B) as follows: 0–22 min, from 5 to 95% B; 22–29 
min, 95% B; 29–31 min, 5% B; 31-40 min, column equilibration with 5% B. Column 
temperature was maintained at 55°C. A complete pigment spectrum (270 to 700 nm) was 
recorded using the PDA detector. Response factor measurement was performed using pigment 
standards obtained from DHI, Denmark.
2.6.4. C30H52O3 and protopanaxadiol profiling
Chemical profile of MeJa treated and control C. reinhardtii cells and protopanaxadiol 
standard (10µg/mL in MeOH) were analysed using 6550 iFunnel Q-TOF LC-MS (Agilent 
Technologies, Santa Clara, CA, USA) equipped with Dual AJS ESI, coupled with an 1260 
infinity HPLC system (Agilent Technologies, Santa Clara, CA, USA). Separation was 






























































μm). The HPLC program consisted of a linear gradient of  A (milli-Q water with 1 % formic 
acid) to B (100% acetonitrile with 1% formic acid) over 25 min, followed by isocratic elution 
at B at a flow rate of 1 mL min−1. Nitrogen was used as the nebulizing gas. Dual Automatic 
Jet Stream (AJS) Electrospray Ionisation (ESI) source was kept at a voltage of 3500 V in 
positive ion mode. Mass spectra were acquired with source conditions as follows: gas 
temperature 350°C, drying gas 4 L min-1 (N2), nebulizer pressure 35 psi (N2) and Vcap 3,500 
V, fragmentor 160V and skimmer 65 V. The mass range scanned was 70–1100 m/z. 
2.7.  Gene expression (qPCR) 
The present study conforms to the Minimum Information for Publication of Quantitative 
Real-Time PCR guidelines [30]. In this section, we indicate the essential information, sensu 
Bustin et al. (2009), required to allow reliable interpretation of the corresponding RT-qPCR 
results.
2.7.1. Primer design
The transcript sequences coding for the enzymes of the methylerythritol phosphate (MEP) 
pathway, the FPP synthase (FPPS), the cycloartenol synthase (CAS), the squalene 
monooxygenase, the sterol C-14 demethylase (CYP51), and delta14-sterol reductase 
(EGR4/24) were obtained from the Phytozome Chlamydomonas reinhardtii v5.5 database 
(https://phytozome.jgi.doe.gov). The transcript sequences were blasted for functional domains 
(Blastx, https://blast.ncbi.nlm.nih.gov/Blast.cgi), which were used as template to design 
sequence-specific primers for RT-qPCR using the software Primer3 version 4.1.0 






























































Table 1. Sequence-specific primers used in this study for RT-qPCR analysis. Target 
name, C. reinhardtii gene IDs, primers sequences, amplicons length, melting 
temperatures, and RT-qPCR efficiencies are indicated. DXS: 1-deoxy-D-xylulose 5-
phosphate synthase; DXR: 1-deoxy-D-xylulose 5-phosphate reductoisomerase; CMK: 4-
(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase; MDS: 2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase; IDI: Isopentenyl-diphosphate Delta-isomerase; FPPS: Farnesyl 
pyrophosphate synthase; SQE: Squalene epoxidase; CAS: Cycloartenol synthase; CYP51: 
sterol C-14 demethylase; ERG4/24: delta14-sterol reductase; CBLP: Chlamydomonas β 
subunit-like polypeptide; RPL13: ribosomal protein L13; RPL10a: ribosomal protein L10a.













































































† IDI is predicted to be present in two different isoforms in C. reinhardtii. The absence of amplification for the second isoform 
(Cre11.g467544.t1.1) lead us to focus only on one isoform. 
‡ Enzymatic function: Validated = experimental evidence at protein level and/or experimental evidence at transcript level; Putative = protein 































































2.7.2. RNA extraction and cDNA synthesis
For gene expression analysis, 50 mL aliquots were extracted from the culture flasks at 48 
hours. C. reinhardtii cells were pelleted at 4,000 x g for 5 min at 4°C, rinsed once with PBS 
1x and flash frozen in liquid nitrogen. Frozen pellets were stored at -80 °C until RNA 
extraction. The RNA was extracted by adding 1.5 mL of PureZol (Bio-Rad) to the frozen 
pellet and pipetting up and down 5 times to homogenize. After 5 min incubation at room 
temperature, 300 µL of chloroform was added. The sample was gently mixed for 15 seconds 
and incubated at room temperature for 15 min before being centrifuged at 12,000 x g for 15 
min at 4 °C. The upper phase was recovered and mixed with an equal volume of absolute 
ethanol. The sample was then transferred to an RNeasy mini spin column provided with the 
RNeasy Mini Kit (Qiagen) and the rest of the extraction was performed according to 
manufacturer's instructions. Column purification was carried out to remove gDNA using 
PureLink™ DNase (Life Technologies). The RNA quantity was assessed by 
spectrophotometry (NanoDropTM, 2000, Thermo Scientific). The quantity of RNA was 
normalized to 1 µg in all the samples, for accurate comparison between treatments, and used 
for further cDNA synthesis. The cDNA was generated using an iScript cDNA Synthesis Kit 
(Bio-Rad) following the manufacturer’s instructions and stored at -20 °C.
2.7.3. RT-qPCR
RT-qPCR gene expression quantification was performed in three technical replicates using 
iTaq UniverSYBR Green Master Mix (Bio-Rad) on a Real-Time PCR System (CFX384™, 
Bio-Rad). A total volume of 10 µL per reaction was used with 1:20 dilutions of cDNA from 
control and treated C. reinhardtii cells and 100 nM of each specific primers (final 
concentration). The Hard-Shell® 384-Well PCR plates (Bio-Rad) were filled with a robot 






























































conditions: incubation at 95 °C for 10 min, then 44 cycles of 95 °C, 60 °C, 68 °C for 30 s 
each, followed by a melt curve. A “no template” control along with a “no reverse 
transcription” control were generated for each gene and each treatment to ensure that the PCR 
reactions were free of genomic DNA contamination. Repeatability of the assay between the 
technical replicates was consistent across the different genes with the replicate variability 
falling within the set limit of <0.5 cycles for all the sample-gene combinations tested.
2.7.4. Data acquisition
The RT-qPCR data were analysed in regression mode using the CFX ManagerTM 3.1 
Software. The RT-qPCR efficiency for each gene and each treatment was determined against 
a standard curve (cDNA dilution gradient of 243, 81, 27, 9 and 3 ng) and a linear regression 
model [36]. The corresponding RT-qPCR efficiencies were calculated according to the 
equation described by Radonić et al. [37]:
𝑃𝐶𝑅 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = (10[ ‒  
1
𝑠𝑙𝑜𝑝𝑒] ‒ 1) ×  100
All of the RT-qPCR efficiencies obtained for the different primers were between 80 and 
101% (Table 1), with a calibration coefficient >0.95 as previously recommended [30]. 
Expression levels of the target genes were normalized against the three reference genes 
(CBLP, RPL13, RPL10a; Table 1) to obtain Normalized Relative Quantities (NRQ). 
2.8.  Statistical analyses
Statistical analyses were done in GraphPad Prism 5.0 Kolmogorov-Smirnov and Levene’test 
were used first to confirm normality and homoscedasticity of the data respectively, and 
parametric tests (ANOVA and unpaired t-test) were applied accordingly. Significant effects 






























































Dunnett's test for the RT-qPCR data and a two-tailed unpaired t-test for the metabolite 
concentrations. The analyses tested the null hypothesis that there was no difference in growth, 
chlorophyll a fluorescence, gene expression and metabolites abundance between the MeJA-
elicited and control treatments. The results were considered significant at P < 0.05 
(Table A1). Throughout the paper, values given are mean ± SEM (n = 3 biological replicates). 
3. RESULTS AND DISCUSSION
3.1.  Potential absence of a plant-like MeJA response machinery in C. 
reinhardtii
Higher plants respond to methyl jasmonate (MeJA) through a complex signalling cascade that 
triggers profound transcriptional, translational and metabolic reprogramming of cell 
physiology. In A. thaliana the upstream players and regulators of this mechanism include 
coronatine- insensitive-1 (COI1) factor, cullin-1 (CUL1), the transcriptional regulator MYC2 
and members of the Jasmonate Zim domain (JAZ) protein family [38, 39]. The proteome of 
C. reinhardtii was mined for orthologs or proteins related to COI1, CUL1, MYC2 and JAZ 
proteins, but no significant matches to the query proteins could be identified, with the 
exception of a homolog of CUL1 (Cre17.g734400.t1.1). C. reinhardtii possesses at least three 
members of the Cullin protein family (Cre17.g734400.t1.1, Cre07.g324050.t1.2 and 
Cre12.g516500.t1.1), which are knowingly involved in protein degradation mechanisms, and 
widely conserved in eukaryotes [40]. Although it cannot be excluded that a plant-like 
mechanism of MeJA response involving Cre17.g734400.t1 may exist in C. reinhardtii, the 
lack of homologues of key components such as COI1, MYC2 and JAZ proteins, based on our 






























































reinhardtii cultures are experimentally treated with sufficient concentration of MeJA, the alga 
showed a marked physiological and metabolic shift, similar to those generally observed in 
higher plants [25]. This may suggest the existence of a possibly distinct but convergent MeJA 
reception and signal transduction mechanism in green algae.
3.2.  Effect of MeJA on cell growth and photosynthetic activity
The treatment of C. reinhardtii cells with 1 mM of MeJA arrested the growth (two-way 
ANOVA: F6, 16 = 7.161, p = 0.0008; post-hoc Tukey’s HSD p < 0.0001; Table A1) and 
significantly reduced the photosynthetic activity of the cells (two-way ANOVA: F6, 16 = 
5.623, p = 0.0026; post-hoc Tukey’s HSD p < 0.01; Table A1). Lower concentrations of 
MeJA did not show significant effect (Figure 2). After 48 hours of incubation with 1 mM of 
MeJA the growth was halted but no signs of apoptosis or cell lysis were observed (Figure 
A1). A study by Lee et al. [25] reported similar results, with a full inhibition of C. reinhardtii 
growth after treatment with 1 mM of MeJA, while only a partial inhibition was observed at a 
concentration of 0.5 mM. Lee et al. study also indicated that MeJA-mediated growth 
inhibition was associated with perturbations in central carbon and saturated fatty acid 
metabolisms of C. reinhardtii. In higher plants, MeJA has been shown to broadly divert 
carbon allocation from primary metabolism to secondary metabolism [18], which is often 
accompanied by a decrease in cell growth [24, 41]. The inhibitory effect of MeJA on plant 
growth is not attributable to cell death, but rather to perturbations of the cell cycle progression 
[15, 24, 42]. 
The maximum quantum yield of photosystem II (PSII) dropped from 0.84 ± 0.04 to 






























































(Figure 2B). In plants, genes involved in photosynthesis, such as ribulose bisphosphate 
carboxylase/oxygenase, chlorophyll a/b-binding protein, and light-harvesting complex II have 
been shown to be downregulated following MeJA treatment [16]. Reduced chlorophyll a 
content have been reported in plants [43, 44] as well as the marine red macroalga Gracilaria 
dura [45] when exposed to MeJA. In C. reinhardtii, a lower photosynthetic activity is likely 
to negatively impact cell growth as the cell is impaired in its capacity to generate energy from 
light. This could partly explain the lower cell density observed 48 hours after MeJA treatment 
(1 mM).
Figure 2. Effect of MeJA concentrations (0, 0.05, 0.5 and 1 mM) on the growth (A) and 
photosynthetic activity (B) of C. reinhardtii cells. The initial 0 hour represents the time at 
which the cells were treated with MeJA. *Significant difference (post-hoc Tukey's HSD, 
P<0.05) between the control (0 mM) and the 1 mM treatment. Mean ± SEM is shown (n = 3).
3.3.  Transcriptional up-regulation of the MEP pathway in MeJA-elicited 
microalgae 
Given the elicitory effect of MeJA on terpenoid production in higher plants, we hypothesized 






























































pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) are the universal building 
blocks of all terpenoids. In the absence of the mevalonate (MVA) pathway, these precursors 
are solely synthesized by the methyl-D-erythritol 4-phosphate (MEP) pathway in C. 
reinhardtii [46]. Therefore, the expression levels of five key genes of the MEP pathway were 
investigated after exposure to MeJA (Figure 3A). Due to significant effects observed on 
growth and quantum yield of PSII, gene expression data were collected at 48 hours of MeJA 
treatment. These genes encode the enzymes 1-deoxy-D-xylulose 5-phosphate synthase (DXS, 
Cre07.g356350.t1.1), 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR, 
Cre12.g546050.t1.2), 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase (CMK, 
Cre02.g145050.t1.2), 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MDS, 
Cre12.g503550.t1.2) and isopentenyl-diphosphate delta-isomerase (IDI, Cre08.g381800.t1.1). 
Two isoforms of IDI are predicted to be present in C. reinhardtii, but only one was 
successfully amplified in this case. Concentration of MeJA up to 0.5 mM did not have a 
significant effect on transcript levels, while the highest concentration of MeJA (1 mM) 
triggered a clear up-regulation of the genes encoding five key enzymes (Table A1, Figure 
3A). Importantly, the over-expression of genes encoding the enzymes up-stream of MEP 
formation are matched by expression levels of transcripts encoding enzymes downstream of 
MEP to avoid pathway bottlenecks, especially the “gatekeeper” enzymes DXS and IDI. 
DXS and HDR, and to some extent DXR, are known to play a major role in the control of flux 
in the MEP pathway of higher plants [11, 47, 48]. Transgenic Arabidopsis plants that over- or 
underexpress DXS respectively accumulated more or less isoprenoids (chlorophylls, 
tocopherols, carotenoids, abscisic acid, and gibberellins) compared with wild-type plants [49], 
demonstrating that DXS catalyzes one of the rate-limiting steps of the MEP biosynthetic 






























































and DMAPP synthesis [47]. However, unlike DXS, the regulation of these two enzymes 
appears to vary among plants and in different conditions. As of today, DXS represents the 
most obvious target for the manipulation of the isoprenoid metabolism. Enfissi et al. [50] 
demonstrated a 1.6-fold increase in the carotenoid content of transgenic tomato lines 
containing a bacterial dxs targeted to the plastid, while a 7-fold increase in phytoene was 
reported in potato tubers engineered with a bacterial dxs gene [51]. Lauersen et al. [12] 
observed similar results in C. reinhardtii with the expression of an heterologous DXS (from 
Salvia pomifera), which increased flux towards heterologous diterpenoids through the MEP 
pathway. However, simultaneous expression of DXS and the downstream enzyme 
geranylgeranyl pyrophosphate synthase (GGPPS) as a fusion protein had a similar effect to 
overproduction of either target alone, suggesting that the cell has a natural tolerance to 
increased flux through the MEP pathway as long as there is a sink for the end product [12]. 
The over-expression of heterologous diterpene synthase did not outcompete native 
mechanisms for GGPP channeling, as the levels of downstream carotenoids and chlorophylls 
were unchanged [12]. These results indicate that the cell has other mechanisms in place to 
compensate for modifications in the MEP pathway than transcriptional up-regulation. In other 
words, small variations in transcript abundances may change flux ratios, but when the cell is 
responding to a stress other regulations mechanisms such as post-translational regulations can 
play a major role. In higher plants mutants affected in any particular step of the MEP 
pathway, low transcript levels of the pathway genes correlates with the low abundance of the 
corresponding enzymes, except for the DXS and HDR proteins, strongly suggesting a post-
translational regulatory mechanism for these two enzymes [47, 48]. Also, the current study 
looked mostly at changes in transcripts level following MeJA treatment, regulation at the 






























































change in dxs transcript level after treatment with 1 mM MeJA (Figure 3A) could suggest that 
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Figure 3. Effect of MeJA on the MEP pathway of C. reinhardtii after 48 hours of 
treatment. A. Relative expression level (Normalized relative quantity, NRQ) of five genes of 
the MEP pathway in cells treated with 0, 0.05, 0.5 and 1 mM of MeJA, Mean ± SEM, n=3, 
each dot represent a sample. *Significant difference (Dunnett’s, P<0.05) between the control 
(0 mM) and the treatment at 48 hours. B. Schematic of the MEP pathway. C. Concentrations 






























































concentrations of MeJA were not investigated here as they did not affect the gene expression. 
Mean ± SEM is shown (n = 3) and unpaired t-test determine statistical significance between 
the control (0 mM) and the 1 mM treatment (p < 0.05 [*]). GAP: D-glyderaldehyde 3-
phosphate; DXS: 1-deoxy-D-xylulose 5-phosphate synthase gene; DXP: 1-deoxy-D-xylulose 
5-phosphate; DXR: 1-deoxy-D-xylulose 5-phosphate reductoisomerase gene; MEP: 2-C-
methyl-D-erythritol 4-phosphate; CMS: 2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase gene; CDP-ME: 4-(cytidine 5’-diphospho)-2-C-methyl-D-erythritol; 
CMK: 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase gene; CDP-MEP: 2-
phospho-4-(cytidine 5’-diphospho)-2-C-methyl-D-erythritol; MDS: 2-C-methyl-D-erythritol 
2,4-cyclodiphosphate synthase gene; MEcPP: 2-C-methyl-D-erythritol-2,4-cyclodiphosphate; 
HDS: (E)-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase gene; HMBPP: 1-hydroxy-2-
methyl-2-(E)-butenyl 4-diphosphate; HDR: 4-hydroxy-3-methylbut-2-enyl diphosphate 
reductase gene; DMAPP: Dimethylallyl diphosphate; IPP: Isopentenyl diphosphate; IDI: 
Isopentenyl-diphosphate Delta-isomerase gene.
3.4.  Effect of MeJA on MEP pathway intermediates, prenyl phosphates and 
pigments
The increase in gene expression was correlated with an increase in abundance of 2-C-methyl-
D-erythritol 4-phosphate (MEP) and 2- C-methyl-D-erythritol-2,4-cyclodiphosphate 
(MEcPP), with significantly higher concentrations observed in the MeJA-treated cells than in 
that of the control (Table A1, Figure 3C). MEP and MEcPP play a central role in the 
regulation of the MEP pathway and stress response in plants [52, 53]. In the plastids of higher 
plant cells, MEP is the first committed precursor of the pathway and activates the expression 






























































molecule that directly or indirectly coordinates the expression of nuclear genes encoding 
plastid-localized proteins in plants [53]. This MEcPP mediated signalling activity is transient 
and can occur only under specific abiotic stresses [52]. The transporter responsible for the 
transport of plastid-localized MEcPP to the nucleus has not yet been identified in plants [55], 
however, it is known for bacteria [56]. Overall, we provide evidence of a marked up-
regulation of the MEP pathway in both transcripts and metabolites following treatment with 
MeJA (Figure 3). 
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Figure 4. Effect of MeJA on triterpenoid biosynthesis. A. Conceptual diagram of the effect 






























































proven (in this study) to be over-expressed are displayed in red, the downregulated 
metabolites are in blue. The genes not showing significant regulation are displayed in black. 
Dashed arrows indicate multiple enzymatic steps. An uncharacterised pathway branch (in 
green) hypothetically stems from either (S)-2,3-epoxysqualene or cycloartenol steps. B. 
Relative expression level of SQE, CAS, CYP51 and ERG4/24 in cells treated with 0, 0.05, 0.5 
and 1 mM of MeJA for 48 hours. Mean ± SEM (n = 3). C. Relative quantity of squalene, (S)-
2,3-epoxysqualene, cycloartenol, ergosterol and 7-dehydroporiferasterol in the control (0 
mM) and the treated cells (1 mM) after 48 hours. ND = Not Detected. Mean ± SEM is shown 
(n = 3) and unpaired t-test determine statistical significance between the control (0 mM) and 
the 1 mM treatment (p < 0.05 [*]). D. Pigment concentrations in control (0 mM) and 1 mM 
MeJA treated cells after 48 hours of treatment. Mean ± SEM is shown (n = 3) and unpaired t-
test determine statistical significance between the control (0 mM) and the 1 mM treatment (p 
< 0.05 [*]). GAP: D-glyderaldehyde 3-phosphate; DMAPP: Dimethylallyl diphosphate; IPP: 
Isopentenyl diphosphate; IDI: Isopentenyl-diphosphate Delta-isomerase gene, FPPS: farnesyl 
diphosphate synthase gene; GGPPS: geranylgeranyl pyrophosphate synthase gene; GGPP: 
geranylgeranyl pyrophosphate; FPP: farnesyl pyrophosphate; SQS: squalene synthase gene, 
SQE: squalene epoxidase gene; CAS: cycloartenol synthase gene; CYP51: sterol C-14 
demethylase gene; EGR4/24: delta14-sterol reductase gene.
The shift in metabolism towards the production of DMAPP and IPP suggests a possible 
accumulation of the prenyl phosphates geranyl pyrophosphate (GPP), geranylgeranyl 
pyrophosphate (GGPP) and farnesyl pyrophosphate (FPP) in the cells treated with MeJA. 
While GPP was not detected in the samples, the concentrations of FPP and GGPP were 
significantly higher in the treated cells compare with the control (Figure 4C). C. reinhardtii 






























































probably present at concentration too low to be detected. The increase in accumulation of 
GGPP in treated C. reinhardtii implies an effect of MeJA on the synthesis of diterpenoids, 
carotenoids and phytoenes. However, the concentrations of chlorophyll a, b and -carotene 
were lower in the treated cells than in the controls (Figure 4D). These results correlate with 
the decrease in the photosynthetic activity of photosystem II observed previously (Figure 2B) 
and illustrate the diversion of IPP and DMAPP away from chlorophylls and -carotene 
towards biosynthesis of sterols and/or other pigments. The occurrence of a metabolic shift 
towards the formation of triterpenoid metabolites such as sterols is also supported by the 
dramatic increase in accumulation of FPP. The rest of this study focuses mainly on 
triterpenoid synthesis, starting with the analysis of the expression of the gene encoding the 
FPP synthase (FPPS, Cre03.g207700.t1.1). Despite the clear effect at the metabolite level, the 
expression of the FPPS gene was unaffected by the treatment with MeJA (Figure 4B). This 
suggests regulation at the translational or post-translational level, rather than at the 
transcriptional level, or that Cre03.g207700.t1.1 does not encode a FPPS, since the function 
of this gene has never been experimentally proven in C. reinhardtii. 
3.5.  Accumulation of triterpenoid precursors and decrease in main sterols 
abundance in MeJA-elicited cells 
C. reinhardtii membranes contain ergosterol and 7-dehydroporiferasterol as main sterols and 
these are synthesised from squalene, through the formation of cycloartenol, by a pathway that 
resembles that of higher plants [57]. Squalene, the C30 precursor of triterpenoids, is the result 
of the condensation of two FPP molecules (Figure 4A). Targeted analyses showed a four-fold 
accumulation of squalene in the elicited-cells (1 mM MeJA) compared to the control 48 hours 






























































accumulation of (S)-2,3-epoxysqualene and the up-regulation of the gene encoding squalene 
epoxidase (SQE, Cre17.g734644.t1.1), the enzyme catalysing the oxidization of squalene in 
(S)-2,3-epoxysqualene (Figure 4). 
Although the increased accumulation of squalene in C. reinhardtii cells following MeJA 
treatment was previously reported [25], the present study is the first to demonstrate the effect 
of MeJA on the up-regulation of SQE transcripts in C. reinhardtii. According to BLAST 
searches and knockdown experiments [35], C. reinhardtii only has one conventional SQE 
(CrSQE), which differs from diatoms and other microalgae. These organisms have recently 
been determined to use an alternative SQE (AltSQE, [27]). SQE is an important point of 
regulation and rate-limiting step in sterol and triterpenoid biosynthesis [58]. According to the 
current literature, most plants have two or more copies of SQE genes [58]. In Panax ginseng, 
the two SQE genes (PgSQE1 and PgSQE2) have been shown to be differentially regulated by 
MeJA treatment [58]. While MeJA enhanced the expression of the PgSQE1 gene, which is 
suspected to contribute to ginsenoside biosynthesis, it did not affect the expression of 
PgSQE2 gene involved in phytosterol production. Similarly, in Medicago truncatula, one 
squalene epoxidase gene (MtSQE2) was up-regulated by treatment with MeJA leading to the 
accumulation of triterpenes, while the sterol composition and the second squalene epoxidase 
gene (MtQSE1) remained unaffected [59]. In this study, we showed that CrSQE expression is 
sensitive to MeJA.
In MeJA treated C. reinhardtii cultures, the increased accumulation of (S)-2,3-epoxysqualene 
was correlated with a decrease in the abundance of the key sterol intermediate cycloartenol, a 
direct product of the cyclisation of (S)-2,3-epoxysqualene catalysed by the cycloartenol 






























































dehydroporiferasterol (Figure 4). Surprisingly, we detected yet uncharacterised triterpenoid-
based molecules in samples treated with MeJA (Figure 5). These compounds eluted at Rt 
24.2 min (m/z 461) and 25.0 min (m/z 461). High resolution mass spectrometry (HRMS) and 
fragmentation pattern were indicative of compounds with molecular formula C30H52O3, 
possibly two different isomers (Figure A2). The chemical formula and mass spectrum 
correspond to protopanaxadiol-type triterpene saponins, which have been shown to be over-
produced in Panax ginseng roots treated with MeJA [60, 61]. The peaks were compared to the 
analytical standard of protopanaxodiol, but the latter eluted at a different retiention time 
(Figure 5). More work is currently been undertaken to elucidate the structure of these 
triterpenoid-based molecules. The mass spectrum (Figure A2) reveals that the molecule 
contains three hydroxyl groups and is likely to be derived from the double hydroxylation of 
either the (S)-2,3-epoxysqualene - as in the case of saponin biosynthesis - or cycloartenol. 
Both (S)-2,3-epoxysqualene and cycloartenol have the same chemical formula (C30H50O) and 
a mass of 426 Daltons, which is two hydroxyl groups away from the 460 Daltons molecule. 
The simultaneous increase in (S)-2,3-epoxysqualene and decrease in cycloartenol content 
coupled with the accumulation of this new triterpenoid compounds suggests a hypothetical 
pathway branching that uses either (S)-2,3-epoxysqualene or cycloartenol as a substrate 
(Figure 4). To outline the presence of a putative branching node, the expression of key sterol 
genes in C. reinhardtii were analysed. Expression data of CAS (Cre01.g011100.t1.2), sterol 
C-14 demethylase (CYP51, Cre02.g092350.t1.2), and delta14-sterol reductase (EGR4/24, 
Cre02.g076800.t1.2) genes did not show a clear down or up-regulation as no significant 
differences with the control (0 mM) were observed (Figure 4B, Table A1). These 
inconclusive results did not provide sufficient transcriptomic clues to determine whether the 
pathway branching occurs right after the conversion of squalene to (S)-2,3-epoxysqualene or 






























































Numerous studies performed on higher plants show the same effect with an increased content 
of triterpenoids directly synthesized from (S)-2,3-epoxysqualene and an associated decrease 
in sterol synthesis downstream from cycloartenol after treatment with MeJA [59, 62, 63]. 
Mangas et al. (2006) previously reported that the induction of nor-seco-friedelane 
galphimines synthesis (triterpenoids derived from (S)-2,3-epoxysqualene) was coupled with 
the inhibition of sterol synthesis by MeJA in the plant Centella asiatica [62]. In the same 
plant elicited with MeJA, Kim et al. [63] showed an upregulation of -amyrin synthase 
(CabAS), a key enzyme in the biosynthesis of triterpene saponins, and the downregulation of 
cycloartenol synthase gene (CaCAS). Furthermore, Suzuki et al. [59] reported an 
accumulation of saponins (triterpene aglycone) derived from β‐amyrin, a product of the 
cyclization of (S)-2,3-epoxysqualene, and a significant reduction in CAS transcript levels 
following MeJA-elicitation of Medicago truncatula. MeJA seems to have a clear effect on 
triterpenoids accumulation and cycloartenol synthase downregulation in higher plants. 
Transposed to C. reinhardtii, these results could suggest that the branching pathway uses (S)-
2,3-epoxysqualene as substrate.
Figure 5. Detection of uncharacterised triterpenoid-based molecules in MeJA-treated 






























































molecules of same formula (C30H52O3) in the C. reinhardtii cells treated with 1 mM of MeJA 
(red) compared to the untreated cells (black) at 48 hours and the protopanaxadiol standard 
(blue). Data from one representative sample out of 3 biological replicates. 
3.6.  Effect of growth conditions on isoprenoid metabolic flux
Among environmental factors, light appears to have the most profound effect on the control 
of MEP-pathway flux [48]. In A. thaliana, light induces the accumulation of transcripts from 
the MEP-pathway genes and genes encoding enzymes of downstream pathways, such as 
carotenoid and chlorophyll biosynthesis [48]. Furthermore, the expression of AtDXS and 
AtHDR follows a circadian pattern, with levels of transcripts increasing and decreasing at day 
and night-time respectively [48]. In C. reinhardtii, the production of an heterologous 
diterpenoid (13R(+) manoyl oxide) in the chloroplast was higher in photoautotrophic 
conditions (CO2 as sole carbon source) in day:night illumination cycles than in continuous 
light [12]. The production of the sesquiterpene biodiesel precursor (E)-α-bisabolene in the 
cytosol also showed to benefit from light:dark cycles, but mixotrophy (with acetate) yielded 
three times more bisabolene than autotrophy [13]. Environmental factors seem to affect the 
production of terpenoids depending on their localization within the cell, with the production 
of diterpenes in chloroplast being affected by light, while the production of sesquiterpenes in 
the cytosol is influenced by the carbon source. Lauersen et al. [9] observed that the abundance 
of FPP varies in C. reinhardtii depending on the carbon-regime, in this case acetate or CO2. 
Therefore, the production of native triterpenoids in C. reinhardtii is likely to be affected, to 
some extend, by the growth conditions. The transcriptomic datasets available on Phytozome 
(https://phytozome.jgi.doe.gov) showed that the target genes investigated in this study are 
differently regulated under different growth conditions (Supplementary Table A2), with some 






























































regulations to our findings because (i) qPCR data and FPKM values are not directly 
comparable and (ii) most of datasets on Phytozome lack precise information about 
experimental conditions. The current study was conducted in mixotrophy (acetate) at constant 
low-light (up to 50 μmol photon m-2 s-1). Some could argue that due to the difference in cell 
density between the control and the treatment after addition of MeJA, the growth conditions 
in the control and the treatment are slightly different (e.g. light exposure per cell) and could 
therefore influence the differences observed in metabolites concentrations. To address this 
question, future works will investigate the production of triterpenoids when the cells are 
exposed to high-light (over 300 μmol photon m-2 s-1) or under photoautotrophic conditions 
and compare to the concentrations obtained under MeJA-elicitation. Ultimately, 
photoautotrophy (i.e. using light and CO2 as sole inputs) is the preferred condition for 
commercial production of terpenoid in a sustainable manner. 
Finally, as a future perspective, it would be interesting to assess the productivity of C. 
reinhardtii strains engineered to produce each sesqui-, di-, and tri-terpenoids upon MeJA 
treatment. While strains producing heterologous sesqui- and di-terpenoids are already 
available [9, 12], C. reinhardtii strains producing heterologous triterpenoids could be created 
as shown in P. tricornutum [10]. 
4. CONCLUSIONS
This study showed that a 48 h-treatment of C. reinhardtii cells with 1 mM of MeJA arrested 
the growth and significantly impaired the photosynthetic activity, while up-regulating the 
MEP pathway leading to the accumulation of the triterpenoids precursors farnesyl 






























































was associated with a decrease in cycloartenol and main sterols of C. reinhardtii. Coupling 
metabolite profiling of elicitor-treated microalgae cells with gene expression analysis lead to 
new understandings in the regulation of isoprenoids and triterpenoids. This study also brought 
new insights in MeJA signalling, which is central in plant sciences. We suggested that the 
signalling mechanisms evolved independently, since C. reinhardtii seems to lack orthologs of 
key genes involved in MeJA signalling in plants. We provided evidence of the accumulation 
of a novel, likely specialised and uncharacterised triterpenoid secondary metabolite, and 
hypothesized the presence of a specialised pathway branching just upstream of cycloartenol. 
Further research is necessary and currently ongoning in our laboratory to identify and 
characterise metabolites and enzymes involved in this hypothetical metabolic branching in the 
triterpenoid metabolism of C. reinhardtii. This work represents one of the first efforts aimed 
at elucidating the regulation of terpenoid metabolism in C. reinhardtii, which is the most 
common model organism for algal biology and biotechnology. The knowledge generated by 
this work sets the basis for more detailed gene discovery experiments that will guide 
metabolic engineering and synthetic biology approaches for the heterologous production of 
terpenoids in algae. 
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Table A1. Analyse of variance using GraphPad Prism 5.0 software to test the dissimilarities 
in quantum yield, cell density, metabolites concentrations and differential expression of key 
metabolic genes in control and MeJA-treated cells of Chlamydomonas reinhardtii. Df = 
degrees of freedom; MS = mean sum of squares. Bold face indicates statistical significance (P 
< 0.05). 
A. Two-way ANOVA and post-hoc Tukey's HSD test results for the quantum yield data.
Source of Variation Df MS F P value
Interaction 6 0.007007 5.623 0.0026
Time 2 0.003751 3.01 0.0777
Treatment 3 0.006066 1.189 0.3736
Tukey's multiple comparisons test
Mean Diff. Significant? Summary Adjusted P Value
0 hour
0 mM vs. 0.05 mM -0.01467 No ns 0.9840
0 mM vs. 0.5 mM 0.002333 No ns >0.9999
0 mM vs. 1 mM 0.011 No ns 0.9931
0.05 mM vs. 0.5 mM 0.017 No ns 0.9756
0.05 mM vs. 1 mM 0.02567 No ns 0.9231































































0 mM vs. 0.05 mM -0.01467 No ns 0.9840
0 mM vs. 0.5 mM -0.02533 No ns 0.9258
0 mM vs. 1 mM -0.03667 No ns 0.8088
0.05 mM vs. 0.5 mM -0.01067 No ns 0.9937
0.05 mM vs. 1 mM -0.022 No ns 0.9495
0.5 mM vs. 1 mM -0.01133 No ns 0.9925
48 hours
0 mM vs. 0.05 mM -0.01633 No ns 0.9782
0 mM vs. 0.5 mM -0.02033 No ns 0.9595
0 mM vs. 1 mM 0.146 Yes ** 0.0082
0.05 mM vs. 0.5 mM -0.004 No ns 0.9997
0.05 mM vs. 1 mM 0.1623 Yes ** 0.0031
0.5 mM vs. 1 mM 0.1663 Yes ** 0.0025
B. Two-way ANOVA and post-hoc Tukey's HSD test results for the cell density data.
Source of Variation Df MS F P value
Interaction 6 1455234787037 7.161 0.0008
Time 2 15238243750000 74.99 <0.0001
Treatment 3 923230925926 8.057 0.0084
Tukey's multiple comparisons test
Mean Diff. Significant? Summary Adjusted P Value
0 hour
0 mM vs. 0.05 mM 283333 No ns 0.8384
0 mM vs. 0.5 mM -133333 No ns 0.9791
0 mM vs. 1 mM -304333 No ns 0.8078
0.05 mM vs. 0.5 mM -416667 No ns 0.6178
0.05 mM vs. 1 mM -587667 No ns 0.3322
0.5 mM vs. 1 mM -171000 No ns 0.9577
12 hours
0 mM vs. 0.05 mM 145333 No ns 0.9733
0 mM vs. 0.5 mM -62000 No ns 0.9978
0 mM vs. 1 mM 180333 No ns 0.9509
0.05 mM vs. 0.5 mM -207333 No ns 0.9281
0.05 mM vs. 1 mM 35000 No ns 0.9996
0.5 mM vs. 1 mM 242333 No ns 0.8913
48 hours
0 mM vs. 0.05 mM -210000 No ns 0.9256
0 mM vs. 0.5 mM 530000 No ns 0.4206
0 mM vs. 1 mM 2210000 Yes **** <0.0001
0.05 mM vs. 0.5 mM 740000 No ns 0.1591
0.05 mM vs. 1 mM 2420000 Yes **** <0.0001
0.5 mM vs. 1 mM 1680000 Yes *** 0.0003
C. One-way ANOVA results for gene expression data at 48 hours of treatment with MeJA.
Genes DF MS F P value
DXS 3 12.04 2.554 0.1285
DXR 3 122.1 7.5 0.0104
CMK 3 3.652 3.821 0.0575






























































IDI 3 58.14 1.388 0.3151
FPPS 3 1.835 0.1236 0.9435
SQE 3 82.48 4.253 0.0451
CAS 3 2.999 2.634 0.1216
CYP51 3 5.834 0.664 0.5972
ERG4/24 3 14.3 0.7222 0.5664
Dunnett's multiple comparisons test (comparing the mean of each treatment with the 
mean of the control)
Genes Mean Diff. Significant? Summary Adjusted P Value
DXS
0 mM vs. 0.05 mM -0.02483 No ns >0.9999
0 mM vs. 0.5 mM 0.01389 No ns >0.9999
0 mM vs. 1 mM -4.01 No ns 0.1249
DXR
0 mM vs. 0.05 mM 0.6167 No ns 0.9950
0 mM vs. 0.5 mM 1.618 No ns 0.9263
0 mM vs. 1 mM -11.94 Yes * 0.0169
CMK
0 mM vs. 0.05 mM 0.4115 No ns 0.9166
0 mM vs. 0.5 mM -0.2937 No ns 0.9659
0 mM vs. 1 mM -2.09 No ns 0.0737
MDS
0 mM vs. 0.05 mM -0.4692 No ns 0.9749
0 mM vs. 0.5 mM -0.7178 No ns 0.9212
0 mM vs. 1 mM -16.91 Yes **** <0.0001
IDI
0 mM vs. 0.05 mM 0.0567 No ns >0.9999
0 mM vs. 0.5 mM 0.6673 No ns 0.9985
0 mM vs. 1 mM -8.543 No ns 0.3114
FPPS
0 mM vs. 0.05 mM 1.362 No ns 0.9469
0 mM vs. 0.5 mM 0.161 No ns >0.9999
0 mM vs. 1 mM 1.492 No ns 0.9327
SQE
0 mM vs. 0.05 mM -0.9324 No ns 0.9872
0 mM vs. 0.5 mM -0.7546 No ns 0.9931
0 mM vs. 1 mM -11.02 Yes * 0.0381
CAS
0 mM vs. 0.05 mM 0.2353 No ns 0.9857
0 mM vs. 0.5 mM -0.06539 No ns 0.9996
0 mM vs. 1 mM -1.926 No ns 0.1346
CYP51
0 mM vs. 0.05 mM 0.6466 No ns 0.9861
0 mM vs. 0.5 mM -0.151 No ns 0.9999
0 mM vs. 1 mM -2.537 No ns 0.6137
ERG4/24
0 mM vs. 0.05 mM 0.9009 No ns 0.9888
0 mM vs. 0.5 mM 0.1606 No ns >0.9999






























































D. Two-tailed unpaired t-test results testing dissimilarities in metabolites concentrations 
between control and treated cells (1mM MeJA) at 48 hours of treatment.
Metabolite t (df) P value
MEP t (4) = 3.069 0.0373
MEcPP t (4) = 4.506 0.0108
GGPP t (4) = 3.881 0.0178
FPP t (4) = 12.99 0.0002
Squalene t (4) = 6.144 0.0036
cycloartenol t (4) = 2.502 0.0666
ergosterol t (4) = 6.415 0.0030
7-dehydroporiferasterol t (4) = 7.305 0.0019
Table A2. FPKM values for genes of interest as reported in Phytozome.
Experiment 
group Experiment Name DXS DXR CMK MDS IDI FPPS SQE CAS CYP51
ERG4
/24
Anaerobiosis CC-124 Dark anoxic .5 hour 93.9 38.972 12.026 67.159 47.594 20.093 14.499 11.011 13.382 6.272
CC-124 Dark anoxic 6 
hours 68.557 58.677 9.885 54.511 15.577 15.824 185.632 24.514 236.999 5.267
CC-124 Light oxic 97.465 64.004 22.566 65.998 15.837 33.691 22.323 15.77 40.129 10.693
crr1 Dark oxic .5 hour 108.694 40.884 7.106 45.291 23.251 11.596 12.99 7.518 8.624 4.938
crr1 Dark oxic 6 hours 
(1) 109.284 45.444 6.619 40.26 21.247 10.044 11.277 11.047 10.553 5.793
crr1 Dark oxic 6 hours 
(2) 90.498 37.926 7.312 31.419 18.384 11.096 10.371 8.948 12.24 6.392
crr1 Light oxic (1) 115.436 57.161 16.202 61.872 16.365 27.095 14.637 8.76 26.43 11.791
crr1 Light oxic (2) 125.261 63.474 16.536 67.366 19.297 20.589 15.021 8.507 23.114 10.663
crr1:CRR1 Dark 
anoxic .5 hour (1) 91.519 38.873 8.618 40.816 21.106 12.608 13.321 5.935 8.147 4.292
crr1:CRR1 Dark 
anoxic .5 hour (2) 74.324 30.533 8.085 36.031 19.009 13.51 13.239 6.741 13.426 6.787
crr1:CRR1 Dark 
anoxic 6 hours (1) 90.585 62.397 4.006 59.431 9.268 14.73 22.066 6.494 16.286 6.734
crr1:CRR1 Dark 
anoxic 6 hours (2) 96.468 43.308 5.717 40.786 18.089 10.131 54.256 13.736 37.194 4.145
crr1:CRR1 Light oxic 
(1) 91.236 52.824 14.882 66.517 16.409 23.368 15.501 8.984 25.058 11.994
crr1:CRR1 Light oxic 
(2) 108.981 62.09 16.924 63.15 15.619 19.019 15.177 8.285 22.41 9.683
crr1dCys Dark anoxic 
.5 hour (1) 82.715 33.924 7.297 43.421 22.778 13.49 11.507 6.642 13.312 7.148
crr1dCys Dark anoxic 
.5 hour (2) 81.715 32.186 8.977 40.994 22.47 16.343 10.853 6.88 15.394 7.041
crr1dCys Dark anoxic 
6 hours (1) 93.594 42.759 11.415 52.198 18.916 13.399 13.058 9.604 23.857 7.238
crr1dCys Dark anoxic 
6 hours (2) 95.519 50.635 11.108 68.242 18.103 15.003 13.846 10.797 36.318 7.753
crr1dCys Light oxic 
(1) 106.146 56.946 16.078 78.432 23.632 23.289 16.036 9.863 27.252 15.554
 crr1dCys Light oxic (2) 102.972 53.802 17.731 70.258 21.39 28.184 15.175 9.498 30.78 15.104
Bilin Signaling 4A+ 0 mM,0.5h white light (1) 254.607 85.813 9.855 117.231 96.502 45.399 80.269 38.73 84.341 50.41
4A+ 0 mM,0.5h white 
light (2) 249.82 84.871 8.264 114.255 94.83 45.608 84.512 40.579 85.569 51.184
4A+ 0 mM,dark (1) 107.473 46.216 10.984 29.458 11.427 28.109 18.051 10.908 34.65 8.184
4A+ 0 mM,dark (2) 102.505 43.87 8.576 27.505 10.902 25.693 17.005 10.532 31.249 6.257
4A+ 0.1 mM BV 
IXa,0.5h white light 
(1)






























































4A+ 0.1 mM BV 
IXa,0.5h white light 
(2)
233.811 75.885 6.219 86.228 66.548 35.657 71.77 39.592 126.38 41.009
4A+ 0.1 mM BV 
IXa,dark (1) 96.49 40.743 8.042 23.596 11.748 20.833 20.541 10.401 26.061 6.367
4A+ 0.1 mM BV 
IXa,dark (2) 92.328 40.085 7.12 23.977 10.847 22.029 18.571 9.205 25.774 6.961
hmox1 0 mM,0.5h 
white light (1) 140.701 72.741 8.585 74.657 60.112 39.92 60.767 24.216 76.397 29.479
hmox1 0 mM,0.5h 
white light (2) 146.772 71.506 8.106 70.017 58.841 38.39 60.673 24.008 78.39 30.799
hmox1 0 mM,dark (1) 88.789 44.346 8.829 30.012 17.056 29.526 20.501 9.568 37.037 7.338
hmox1 0 mM,dark (2) 90.909 45.98 8.526 29.553 16.122 24.224 20.714 9.701 34.759 7.441
hmox1 0.1 mM BV 
IXa,0.5h white light 
(1)
134.564 64.102 8.217 63.176 44.514 37.485 50.24 22.972 90.323 22.575
hmox1 0.1 mM BV 
IXa,0.5h white light 
(2)
144.556 65.175 7.567 64.189 46.251 33.481 52.97 25.011 99.977 22.21
hmox1 0.1 mM BV 
IXa,dark (1) 84.376 43.01 6.955 33.643 15.503 23.104 22.722 9.508 34.276 6.736






143.678 58.931 9.928 51.578 10.126 16.962 71.086 12.155 39.409 8.427
WT-2137 Copper 
deficient (TAP) 5 158.642 81.856 14.301 98.456 18.068 30.729 89.865 17.509 175.773 21.38
WT-2137 Copper 
deficient (TAP) 6 145.907 71.424 22.333 110.119 23.416 31.982 104.775 25.513 183.672 18.071
WT-2137 Copper 












105.652 31.486 7.906 33.59 9.905 16.384 68.73 12.061 58.952 8.272
WT-2137_Copper 
deficient (TAP) 10 105.754 74.668 20.513 105.763 19.184 29.897 112.212 20.081 145.642 17.243
WT-2137_Copper 
deficient (TAP) 8 115.638 81.522 23.887 106.797 20.271 32.665 103.911 22.073 130.105 13.778
WT-2137_Copper 
deficient (TAP) 9 111.442 76.722 21.823 106.856 16.313 29.745 113.236 17.774 142.442 16.362
WT-2137_Copper 
sufficient (TAP) 10 123.001 95.263 27.283 108.094 15.526 35.722 17.41 12.687 29.248 15.518
WT-2137_Copper 
sufficient (TAP) 3 169.302 93.73 35.178 130.859 24.659 45.124 16.087 13.653 41.276 23.551
WT-2137_Copper 
sufficient (TAP) 5 174.76 114.979 15.114 114.48 20.902 38.501 11.545 14.598 32.54 20.938
WT-2137_Copper 
sufficient (TAP) 6 165.877 98.861 25.353 109.15 17.734 37.51 15.355 13.992 37.67 22.006
WT-2137_Copper 
sufficient (TAP) 7 126.431 102.378 25.547 109.438 15.468 33.625 14.576 13.663 28.972 17.446
WT-2137_Copper 
sufficient (TAP) 8 125.103 104.137 23.977 102.806 14.381 28.216 17.56 12.779 30.772 21.702
WT-2137_Copper 
sufficient (TAP) 9 115.352 107.999 27.536 118.052 13.737 32.268 18.967 14.251 30.066 18.377
crr1-2 Copper 
deficient (TAP) 3 94.523 64.352 24.664 49.22 11.147 27.165 45.152 11.135 40.016 10.022
crr1-2 Copper 
deficient (TAP) 4 95.945 79.926 29.655 43.829 9.847 30.682 45.261 14.987 32.357 10.966
crr1:CRR1 Copper 
deficient (TAP) 1 109.851 41.579 21.502 46.53 11.698 31.97 10.935 5.053 13.766 13.727
 crr1:CRR1 Copper deficient (TAP) 2 110.606 39.579 26.511 47.968 12.246 31.091 11.179 5.257 14.129 13.493
Fe Deficiency WT-2137 Fe replete (Minimal media) 1 145.233 37.791 8.247 46.189 19.572 16.581 16.462 11.443 21.048 16.473
WT-2137 Fe replete 






























































WT-2137 Fe replete 
(Minimal media) 3 140.476 45.822 4.46 50.931 23.303 15.271 15.794 12.436 19.223 12.975
WT-2137 Fe replete 
(Minimal media) 4 137.085 45.063 4.462 49.25 23.586 14.255 19.391 12.241 17.89 12.72
WT-2137 Fe replete 
(TAP) 1 101.912 27.588 14.528 42.023 29.716 35.699 16.893 10.835 26.952 20.222
WT-2137 Fe replete 
(TAP) 2 90.594 31.243 9.96 44.283 32.188 33.899 14.85 9.857 30.391 18.221
WT-2137 Fe-deficient 
(Minimal media) 1 135.963 35.12 4.289 47.059 23.264 17.852 16.735 10.543 18.662 13.503
WT-2137 Fe-deficient 
(Minimal media) 2 134.279 37.964 6.091 39.706 20.272 16.241 21.087 10.419 17.871 11.304
WT-2137 Fe-deficient 
(Minimal media) 3 129.846 37.993 6.632 47.797 21.414 19.705 12.162 10.567 21.08 12.97
WT-2137 Fe-deficient 
(Minimal media) 4 127.912 39.474 6.705 40.959 21.561 19.592 13.283 10.916 21.322 14.901
WT-2137 Fe-deficient 
(TAP) 1 77.148 20.25 6.97 25.393 28.162 38.091 13.192 9.253 30.233 20.991
WT-2137 Fe-deficient 
(TAP) 2 78.413 25.028 12.416 32.941 24.838 36.526 14.232 11.502 36.347 14.758
WT-2137 Fe-deficient 
(TAP) 3 82.119 24.344 11.045 35.884 25.267 33.658 15.105 10.23 35.262 18.055
WT-2137 Fe-limited 
(Minimal media) 1 133.634 29.037 3.249 33.986 28.541 14.606 18.663 10.379 18.488 17.517
WT-2137 Fe-limited 
(Minimal media) 2 128.205 30.109 3.588 37.21 27.333 14.707 18.543 11.754 16.285 13.675
WT-2137 Fe-limited 
(Minimal media) 3 113.909 25.679 1.919 32.138 30.616 16.6 17.413 10.58 16.164 15.698
WT-2137 Fe-limited 
(Minimal media) 4 117.427 26.498 3.171 29.549 28.53 12.466 17.945 10.632 15.901 14.656
WT-2137 Fe-limited 
(TAP) 1 118.755 50.129 7.672 43.877 51.806 31.552 10.271 14.113 21.493 16.676
WT-2137 Fe-limited 
(TAP) 2 123.811 47.582 10.523 44.717 53.987 29.451 15.227 12.066 19.766 14.812
 WT-2137 Fe-limited (TAP) 3 148.422 48.11 9.142 39.12 59.664 26.286 15.5 11.98 22.708 18.649
GeneAtlas Hetero.Ammonia 43.513 4.534 1.58 10.543 12.112 5.967 4.344 1.572 7.451 4.013
Hetero.Ammonia 
Early 59.978 8.983 7.929 37.815 6.268 10.725 3.484 0.709 10.939 4.351
Hetero.Ammonia 
MidLog 54.53 6.923 4.323 19.756 6.945 15.781 2.977 1.375 14.681 7.081
Hetero.Nitrate 31.83 4.995 7.933 13.626 6.577 19.862 3.845 1.258 27.557 6.256
Hetero.Urea 7.312 1 1.524 8.031 3.019 3.23 1.176 0.161 3.749 0.884
Mixo.Ammonia 83.619 21.501 13.977 38.829 7.973 18.602 4.936 2.05 18.772 6.233
Mixo.Ammonia 
Diurnal 127.897 38.39 29.874 85.09 3.94 17.474 3.77 1.897 14.768 7.663
Mixo.Ammonia Early 72.552 14.7 11.725 36.868 18.19 13.983 5.072 1.895 15.525 6.601
Mixo.Ammonia 
MidLog 80.766 19.486 15.078 40.218 7.958 18.292 4.624 1.647 21.268 6.425
Mixo.HighLight Early 55.154 9.203 9.623 33.609 14.923 14.476 6.345 1.221 12.495 4.961
Mixo.HighLight 
MidLog 67.66 7.69 10.154 55.461 11.374 11.488 5.686 0.777 11.265 5.667
Mixo.Nitrate 74.716 22.384 15.742 35.74 6.165 21.388 4.011 1.653 24.764 6.954
Mixo.Nitrate Diurnal 97.791 31.878 23.61 92.096 3.216 15.145 2.743 0.95 10.224 5.745
Mixo.Urea Diurnal 111.685 36.675 27.574 97.634 2.098 18.172 2.955 1.321 12.488 6.183
MixoUrea 77.086 22.262 16.539 43.779 8.697 20.685 3.772 1.497 20.797 7.048
Photo.Ammonia 85.253 14.252 11.665 30.434 7.562 16.297 4.166 1.745 18.72 5.769
Photo.Ammonia 
Diurnal 128.549 30.839 23.047 62.668 3.912 9.207 3.358 1.955 8.31 5.012
Photo.Ammonia Early 65.414 11.516 8.698 26.593 12.246 13.49 4.771 1.306 14.739 4.571
Photo.Ammonia 
MidLog 78.268 10.752 9.542 26.938 10.123 17.134 4.969 1.577 24.186 6.442
Photo.HighLight Early 46.646 8.069 4.961 18.678 9.621 6.555 5.422 0.699 9.757 3.005
Photo.HighLight 
MidLog 64.828 10.599 6.962 24.092 9.719 10.835 6.547 1.322 16.533 4.911
Photo.Nitrate 60.662 13.052 10.468 28.083 5.588 11.345 2.909 0.908 14.369 4.336






























































Photo.Urea 74.135 12.932 11.303 25.283 6.951 11.449 3.85 1.052 14.709 3.871
 Photo.Urea Diurnal 137.147 31.782 23.907 59.649 2.472 9.821 3.388 1.648 11.33 5.525
H2O2 Treatment Hydrogen peroxide time course .5 hour (1) 172.93 98.996 27.508 94.594 25.777 43.433 39.828 12.648 57.681 19.178
Hydrogen peroxide 
time course .5 hour (2) 152.205 86.592 21.743 91.347 25.001 42.179 33.081 12.767 53.365 17.777
Hydrogen peroxide 
time course 0 hours (1) 180.35 109.114 28.183 102.184 15.158 42.508 19.701 11.25 37.75 11.949
Hydrogen peroxide 
time course 0 hours (2) 151.619 88.359 20.282 86.593 17.608 37.996 18.068 11.942 39.761 14.257
Hydrogen peroxide 
time course 1 hour (1) 145.075 79.585 26.705 97.707 40.526 49.563 44.757 17.45 86.94 27.503
 Hydrogen peroxide time course 1 hour (2) 156.095 79.742 26.228 115.46 41.949 49.7 45.559 16.901 88.986 30.402
N Concentration
WT-2137 Nitrogen 
deficiency first long 
time course 0 minutes 
(1)
215.485 75.241 38.374 90.471 18.629 34.143 22.489 14.479 37.815 14.686
WT-2137 Nitrogen 
deficiency first long 
time course 0 minutes 
(2)
195.446 75.206 28.308 100.204 14.531 30.092 24.511 13.601 36.251 16.243
WT-2137 Nitrogen 
deficiency first long 
time course 30 
minutes (2)
140.952 46.995 14.497 95.011 35.391 25.034 32.197 11.571 50.561 19.616
WT-2137 Nitrogen 
deficiency first long 
time course 30minutes 
(1)
144.702 50.205 12.516 87.548 37.562 20.489 28.429 11.861 60.698 23.126
WT-2137 Nitrogen 
deficiency first long 
time course 4 hours (2)
65.528 16.568 2.782 19.979 17.436 16.71 15.901 6.649 26.163 12.407
WT-2137 Nitrogen 
deficiency first long 
time course 4hours (1)
69.709 15.46 2.41 23.496 14.321 21.603 18.221 6.029 29.011 11.369
WT-2137 Nitrogen 
deficiency first long 
time course 8 hours (1)
77.891 14.856 1.835 23.519 17.191 19.22 16.402 5.36 30.867 16.902
WT-2137 Nitrogen 
deficiency first long 
time course 8 hours (2)
63.683 16.324 0.952 18.688 21.952 17.268 13.168 7.59 27.285 14.807
WT-2137 Nitrogen 
deficiency second long 
time course 0 hours
154.661 67.132 22.087 94.388 8.838 30.684 16.574 10.347 37.273 14.261
WT-2137 Nitrogen 
deficiency second long 
time course 12 hours
73.268 21.808 0.749 29.322 24.735 9.85 11.951 10.125 20.558 12.749
WT-2137 Nitrogen 
deficiency second long 
time course 2 hours
105.32 34.905 9.104 39.067 12.33 11.148 14.591 7.985 23.692 10.259
WT-2137 Nitrogen 
deficiency second long 
time course 24 hours
62.229 26.349 0.68 31.794 15.229 9.778 10.788 7.596 12.876 15.045
WT-2137 Nitrogen 
deficiency second long 
time course 48 hours
52.986 18.016 0.617 33.827 21.957 8.611 5.168 4.606 12.11 14.529
WT-2137 Nitrogen 
deficiency second long 
time course 8 hours
98.952 25.126 0.668 28.644 26.692 10.697 11.033 10.587 17.676 17.96
WT-2137 Nitrogen 
deficiency short time 
course 0 minutes (1)
200.907 99.766 22.56 80.912 31.693 42.602 24.074 17.911 77.369 29.442
WT-2137 Nitrogen 
deficiency short time 
course 0 minutes (2)
209.217 103.107 25.859 92.317 23.401 47.308 21.999 19.061 69.179 24.026
WT-2137 Nitrogen 
deficiency short time 
course 12 minutes
192.558 91.368 19.478 105.04 46.877 32.546 34.577 20.706 100.957 30.272
WT-2137 Nitrogen 
deficiency short time 
course 18 minutes































































deficiency short time 
course 2 minutes
202.748 97.582 20.896 78.682 33.509 34.465 23.783 16.844 71.042 24.969
WT-2137 Nitrogen 
deficiency short time 
course 24 minutes
203.446 108.622 19.14 134.02 70.348 35.731 47.48 23.454 144.739 48.211
WT-2137 Nitrogen 
deficiency short time 
course 30 minutes
189.129 102.947 16.01 186.383 92.807 33.429 45.563 26.786 119.117 43.786
WT-2137 Nitrogen 
deficiency short time 
course 4 minutes
194.451 94.272 27.05 91.424 38.795 35.275 28.136 18.109 73.134 27.582
WT-2137 Nitrogen 
deficiency short time 
course 45 minutes
177.551 76.596 19.434 166.988 81.157 22.445 27.728 25.82 68.038 30.941
WT-2137 Nitrogen 
deficiency short time 
course 60 minutes
127.989 53.496 23.004 112.61 41.323 16.8 19.695 16.724 37.913 19.724
 
WT-2137 Nitrogen 
deficiency short time 
course 8 minutes
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0 12 24 48
Figure A1. Percentage of dead cells in cultures of control (0 mM) and 1 mM MeJA treated 
cells. The initial 0 hour represents the time at which the cells were treated with MeJA. C. 
reinhardtii cells were stained with the LIVE/DEAD™ Fixable Violet Dead Cell Stain Kit 
(ThermoFisher) and then analysed by flow cytometry. Mean ± SEM is shown (n = 3) and 
unpaired t-test determine statistical significance between the control (0 mM) and the 1 mM 






























































Figure A2. Mass spectrum of the C30H52O3 molecules.
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